Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Giannelli, Gianluigi; Santoro, Armando; Kelley, Robin K; Gane, Ed; Paradis, Valerie; Cleverly, Ann; Smith, Claire; Estrem, Shawn T et al. · PLoS One · 2021

Where this comes from

Record sourced from PubMed, PMID 34138968.
Also identified by DOI 10.1371/journal.pone.0253671 and PMC identifier 8211152.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0222259.].

Read the full text

View on PubMed · Publisher (DOI)